Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant

Hematol Oncol Stem Cell Ther. 2016 Mar;9(1):36-8. doi: 10.1016/j.hemonc.2015.04.005. Epub 2015 Apr 28.

Authors

N Yafour¹, A Krim², R Bouhass², M A Bekadja²

Affiliations

¹ Department of Hematology and Cellular Therapy, Hospital University Establishment 1st November, Oran, Algeria. Electronic address: Yafour.nabil@yahoo.fr.
² Department of Hematology and Cellular Therapy, Hospital University Establishment 1st November, Oran, Algeria.

PMID: 25979822
DOI: 10.1016/j.hemonc.2015.04.005

No abstract available

Publication types

Letter

MeSH terms

Adult
Anemia, Aplastic / therapy
Brain Stem / drug effects*
Brain Stem / pathology*
Cyclosporine / adverse effects*
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Immunosuppressive Agents / adverse effects*
Male
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / etiology
Posterior Leukoencephalopathy Syndrome / pathology
Young Adult

Substances

Immunosuppressive Agents
Cyclosporine